Latest Regulatory News

Bougainville Copper Limited remains inactive in production but advances talks with international mining firms to revive the long-dormant Panguna Project, backed by the Autonomous Bougainville Government.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Aurumin Limited has sent out its Scheme Booklet detailing the proposed acquisition by Brightstar Resources, setting the stage for shareholder meetings in November. Securityholders are urged to review the materials carefully before voting.

Triton Minerals advances its graphite sale resolution with NQM while initiating key field activities at the Aucu Gold-Copper Project in Mozambique, alongside launching a shareholder consolidation scheme.

Australia United Mining has responded to ASX inquiries following a sudden surge in its share price and trading volume, confirming no undisclosed information exists and affirming compliance with continuous disclosure rules.

Netlinkz Limited has attributed the late filing of a key director disclosure to an administrative error, while affirming its existing compliance frameworks remain robust.

VHM Limited has secured a significant offtake framework with Mitsui and a US$200 million financing interest from the US Export-Import Bank for its Goschen Rare Earths and Mineral Sands Project, alongside key environmental approvals. These milestones set the stage for a Final Investment Decision in the first half of 2026.

VHM Limited has significantly expanded its Exploration Target at the Goschen Project in Victoria, revealing a potential resource of up to 4 billion tonnes of ore rich in valuable heavy minerals and rare earths. This update underscores Goschen's emerging status as a major player in Australia's mineral sands sector.

ActivEX Limited has completed a significant $800,000 share placement to True Creation Limited, aiming to strengthen its financial footing and advance exploration projects.

Vectus Biosystems has temporarily paused trading of its securities pending a forthcoming announcement, signaling potential material news for investors.

QBE Insurance Group has announced the redemption of its USD 300 million 6.10% fixed rate subordinated notes due 2045, marking a notable step in its capital management strategy with regulatory approval secured.

Biotron Limited is set to acquire Sedarex Limited, gaining global patents for SedRx, a next-generation general anaesthetic, supported by a $2.5 million capital raising to fund regulatory and development milestones.